Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Hamby

Showing results (41-50 of 67) with videos related to

Pageof 7
Sort By:
Forensic Science International|December 3, 1999
Typing of eight short tandem repeat (STR) loci in a Saudi Arabian populationS Sinha, M Amjad, C Rogers, et al.
Scientific Reports|February 10, 2025
Sigma-2 receptor modulator CT1812 alters key pathways and rescues retinal pigment epithelium (RPE) functional deficits associated with dry age-related macular degeneration (AMD)Britney N Lizama, Eloise Keeling, Eunah Cho, et al.
Alzheimer'S Research & Therapy|January 25, 2024
A pilot study to evaluate the effect of CT1812 treatment on synaptic density and other biomarkers in Alzheimer's diseaseChristopher H van Dyck, Adam P Mecca, Ryan S O'Dell, et al.
International Journal of Molecular Sciences|July 15, 2020
Dual Leucine Zipper Kinase Is Constitutively Active in the Adult Mouse Brain and Has Both Stress-Induced and Homeostatic FunctionsSunil Goodwani, Celia Fernandez, Paul J Acton, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 11, 2011
Neuroprotection mediated through estrogen receptor-alpha in astrocytesRory D Spence, Mary E Hamby, Elizabeth Umeda, et al.
Alzheimer'S & Dementia (New York, N. Y.)|June 23, 2025
Identification of cerebrospinal fluid pharmacodynamic biomarkers and molecular correlates of brain activity in a Phase 2 clinical trial of the Alzheimer's disease drug candidate CT1812Valentina Di Caro, Eunah Cho, Hilary A North, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Drug DevelopmentBritney N Lizama, Kiran Pandey, Eunah Cho, et al.
Brain, Behavior, and Immunity|April 25, 2009
To assess, to control, to exclude: effects of biobehavioral factors on circulating inflammatory markersMary-Frances O'Connor, Julie E Bower, Hyong Jin Cho, et al.
Plos One|November 21, 2012
Comparative analysis of genome sequences covering the seven cronobacter speciesSusan Joseph, Prerak Desai, Yongmei Ji, et al.
Alzheimer'S Research & Therapy|April 6, 2026
Impact of zervimesine on the neuroinflammatory biomarker GFAP and related proteomic molecular correlates in plasma of participants from a phase 2 clinical trial in Alzheimer's diseaseValentina Di Caro, Eunah Cho, Jill Thiel, et al.
Pageof 7

Showing results (41-50 of 67) with videos related to

Sort By:
Pageof 7
Forensic Science International|December 3, 1999
Typing of eight short tandem repeat (STR) loci in a Saudi Arabian populationS Sinha, M Amjad, C Rogers, et al.
Scientific Reports|February 10, 2025
Sigma-2 receptor modulator CT1812 alters key pathways and rescues retinal pigment epithelium (RPE) functional deficits associated with dry age-related macular degeneration (AMD)Britney N Lizama, Eloise Keeling, Eunah Cho, et al.
Alzheimer'S Research & Therapy|January 25, 2024
A pilot study to evaluate the effect of CT1812 treatment on synaptic density and other biomarkers in Alzheimer's diseaseChristopher H van Dyck, Adam P Mecca, Ryan S O'Dell, et al.
International Journal of Molecular Sciences|July 15, 2020
Dual Leucine Zipper Kinase Is Constitutively Active in the Adult Mouse Brain and Has Both Stress-Induced and Homeostatic FunctionsSunil Goodwani, Celia Fernandez, Paul J Acton, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 11, 2011
Neuroprotection mediated through estrogen receptor-alpha in astrocytesRory D Spence, Mary E Hamby, Elizabeth Umeda, et al.
Alzheimer'S & Dementia (New York, N. Y.)|June 23, 2025
Identification of cerebrospinal fluid pharmacodynamic biomarkers and molecular correlates of brain activity in a Phase 2 clinical trial of the Alzheimer's disease drug candidate CT1812Valentina Di Caro, Eunah Cho, Hilary A North, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Drug DevelopmentBritney N Lizama, Kiran Pandey, Eunah Cho, et al.
Brain, Behavior, and Immunity|April 25, 2009
To assess, to control, to exclude: effects of biobehavioral factors on circulating inflammatory markersMary-Frances O'Connor, Julie E Bower, Hyong Jin Cho, et al.
Plos One|November 21, 2012
Comparative analysis of genome sequences covering the seven cronobacter speciesSusan Joseph, Prerak Desai, Yongmei Ji, et al.
Alzheimer'S Research & Therapy|April 6, 2026
Impact of zervimesine on the neuroinflammatory biomarker GFAP and related proteomic molecular correlates in plasma of participants from a phase 2 clinical trial in Alzheimer's diseaseValentina Di Caro, Eunah Cho, Jill Thiel, et al.
Pageof 7